Active Ingredient Durvalumab
Active Ingredient Details
What is Durvalumab?
an IgG1 that targets programmed cell death 1 ligand 1 (PD-L1); enhances the immune response to tumor cells and is used for the treatment of locally advanced or metastatic urothelial carcinoma
How many products in the NDC database contain Durvalumab?
The NDC database has 12 products with the active ingredient Durvalumab. The following table lists all the products that have this active ingredient.
NDC Products with Durvalumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0310-4500 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 0310-4611 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 0310-5500 | Proprietary Name: | Durvalumab | Liquid | Astrazeneca Pharmaceuticals Lp | ACTIVE | ||
| 12714-087 | Proprietary Name: | Durvalumab | Solution | Boehringer Ingelheim Pharma Gmbh And Co. Kg | ACTIVE | ||
| 17228-4500 | Proprietary Name: | Durvalumab | Injection, Solution | Astrazeneca Ab | ACTIVE | ||
| 17228-4611 | Proprietary Name: | Durvalumab | Injection, Solution | Astrazeneca Ab | ACTIVE | ||
| 61434-002 | Proprietary Name: | Durvalumab Injection, Solution | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-002 | Proprietary Name: | Durvalumab Injection, Solution | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-002 | Proprietary Name: | Durvalumab Injection, Solution | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-002 | Proprietary Name: | Durvalumab Injection, Solution | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-038 | Proprietary Name: | Durvalumab | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 71124-0030 | Proprietary Name: | Durvalumab | Liquid | Samsung Biologics Co., Ltd. | ACTIVE |
